The current price of ALNY is $156.66 — it has decreased by 2.74% since the previous close. Data as of Nov 5, 2026.
ALNY is down 9.29% over the past week, down 28.76% over the past month and down 63.95% over the past year. The price is below its 200-day moving average of $282.50.
Analysts' average 12-month price target for ALNY is $330.54, which implies 110.99% upside from the current price. Individual estimates range from $225.00 to $455.00.
Of the 31 analysts covering Alnylam Pharmaceuticals, Inc., 7 rate it a strong buy, 15 rate it a buy and 9 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Alnylam Pharmaceuticals, Inc. has a market capitalization of $20.98B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Alnylam Pharmaceuticals, Inc. posted earnings of $16.26 per share against an estimate of $1.66, beating expectations by 879.52%. Upcoming reports are listed in the earnings calendar.
Alnylam Pharmaceuticals, Inc. reported revenue of $1.46B in its most recent quarter, which has increased by 16.74% compared with the same quarter a year earlier. Analysts had expected $1.43B.
Alnylam Pharmaceuticals, Inc. has not paid any dividends over the past year.
Companies most comparable to Alnylam Pharmaceuticals, Inc. include Arrowhead Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Intellia Therapeutics, Inc., Silence Therapeutics plc and Wave Life Sciences Ltd.
In the latest trading session ALNY moved between $156.42 and $168.50, a range of 7.71% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Alnylam Pharmaceuticals, Inc. shows a sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Alnylam Pharmaceuticals, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ALNY has traded between $156.00 and $479.79. The current price is 67.35% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.